741601659	741601659	CD	B-NP	O
|	|	NN	I-NP	O
RCMC	RCMC	NN	I-NP	O
|	|	NN	I-NP	O
36908482	36908482	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0016869	0016869	CD	B-NP	O
|	|	CC	I-NP	O
6/7/2005	6/7/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
11/19/2005	11/19/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NNP	B-NP	O
:	:	:	O	O
BORBA	BORBA	NNP	B-NP	O
,	,	,	O	O
GARRET	GARRET	NNP	B-NP	O
M.D.	M.D.	NNP	I-NP	O
SERVICE	SERVICE	NNP	I-NP	O
:	:	:	O	O
Surgical	Surgical	JJ	B-NP	O
ICU	ICU	NN	I-NP	O
.	.	.	O	O

PRINCIPAL	PRINCIPAL	JJ	B-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Perforated	Perforate	VBN	B-NP	O
colon	colon	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
.	.	.	O	O

ACTIVE	ACTIVE	NNP	B-NP	O
PROBLEMS	PROBLEMS	NNP	I-NP	O
LIST	LIST	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Status	Status	NNP	B-NP	O
post	post	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
,	,	,	O	O
perforation	perforation	NN	B-NP	O
of	of	IN	B-PP	O
colon	colon	NN	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
Adriamycin	Adriamycin	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-NP	O
failure	failure	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
steroid	steroid	NN	I-NP	O
dependent	dependent	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Pseudomonas	Pseudomonas	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Steroid	Steroid	NN	B-NP	O
dependent	dependent	JJ	B-ADJP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Perforated	Perforate	VBN	B-NP	O
colonic	colonic	JJ	I-NP	O
diverticula	diverticula	NN	I-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Sepsis	Sepsis	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Anxiety	Anxiety	NN	B-NP	O
with	with	IN	B-PP	O
adjustment	adjustment	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
.	.	.	O	O

Coronary	Coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
as	as	RB	B-ADVP	O
above	above	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Congestive	Congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
ejection	ejection	NN	B-NP	O
fraction	fraction	NN	I-NP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
ischemic	ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
and	and	CC	I-NP	O
Adriamycin	Adriamycin	NN	I-NP	O
toxicity	toxicity	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Atrial	Atrial	JJ	B-NP	O
fibrillation	fibrillation	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
paroxysmal	paroxysmal	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Nonsustained	Nonsustained	JJ	B-NP	O
ventricular	ventricular	JJ	I-NP	O
tachycardia	tachycardia	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Hypertension	Hypertension	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

Steroid-dependent	Steroid-dependent	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Staphylococcus	Staphylococcus	NN	B-NP	O
bacteremia	bacteremia	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Leg	Leg	NN	B-NP	O
blisters	blister	NNS	I-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Transient	Transient	JJ	B-NP	O
ischemic	ischemic	JJ	I-NP	O
attacks	attack	NNS	I-NP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Gout	Gout	NNP	B-NP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Cholecystectomy	Cholecystectomy	NN	B-NP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Appendectomy	Appendectomy	NN	B-NP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Testicular	Testicular	JJ	B-NP	O
cancer	cancer	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
chemotherapy	chemotherapy	NN	I-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
known	know	VBN	I-NP	O
drug	drug	NN	I-NP	O
allergies	allergy	NNS	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
Achilles	Achilles	NNP	B-NP	O
tendon	tendon	NN	I-NP	O
rupture	rupture	NN	I-NP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Amiodarone	Amiodarone	NN	B-NP	O
,	,	,	O	O
200	200	CD	B-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
,	,	,	O	O
T-tube	T-tube	NNP	B-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Peridex	Peridex	NNP	B-NP	O
,	,	,	O	O
15	15	CD	B-NP	O
mL	mL	NN	I-NP	O
orally	orally	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	B-NP	O
3	3	CD	I-NP	O
.	.	.	O	O

Digoxin	Digoxin	NN	B-NP	O
,	,	,	O	O
0.0625	0.0625	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
T-tube	T-tube	NN	B-NP	B-protein
q.o.d.	q.o.d.	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Pepcid	Pepcid	IN	B-PP	O
20	20	CD	B-NP	O
mg	mg	NN	I-NP	O
T-tube	T-tube	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
4	4	CD	I-NP	O
.	.	.	O	O

Folate	Folate	NNP	B-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
T-tube	T-tube	NNP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Heparin	Heparin	NN	B-NP	O
,	,	,	O	O
5000	5000	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
t.i.d.	t.i.d.	RB	B-ADVP	O
6	6	CD	B-NP	O
.	.	.	O	O

NPH	NPH	NN	B-NP	O
,	,	,	O	O
9	9	CD	B-NP	O
units	unit	NNS	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
q.a.m.	q.a.m.	RB	B-NP	O
7	7	CD	I-NP	O
.	.	.	O	O

Insulin	Insulin	NN	B-NP	B-protein
regular	regular	JJ	I-NP	O
,	,	,	O	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Prednisone	Prednisone	NN	B-NP	O
,	,	,	O	O
5	5	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
T-tube	T-tube	NN	B-NP	B-protein
q.a.m.	q.a.m.	NN	I-NP	I-protein
9	9	CD	I-NP	I-protein
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Sarna	Sarna	NNP	B-NP	O
topically	topically	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

11	11	CD	B-NP	O
.	.	.	O	O

Nystatin	Nystatin	NN	B-NP	O
suspension	suspension	NN	I-NP	O
5	5	CD	I-NP	O
mL	mL	NN	I-NP	O
PO	PO	NN	I-NP	O
q.i.d.	q.i.d.	NN	I-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

Thiamine	Thiamine	NN	B-NP	O
,	,	,	O	O
100	100	CD	B-NP	O
mg	mg	NN	I-NP	O
,	,	,	O	O
T-tube	T-tube	NNP	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Flovent	Flovent	NNP	B-NP	O
,	,	,	O	O
88	88	CD	B-NP	O
mcg	mcg	NN	I-NP	O
MDI	MDI	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
14	14	CD	I-NP	O
.	.	.	O	O

Collagenase	Collagenase	NN	B-NP	B-protein
topically	topically	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Combivent	Combivent	NNP	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
puffs	puff	NNS	I-NP	O
MDI	MDI	NNP	B-NP	O
q.i.d.	q.i.d.	NNP	I-NP	O
16	16	CD	I-NP	O
.	.	.	O	O

Albuterol	Albuterol	NN	B-NP	O
,	,	,	O	O
2	2	CD	B-NP	O
to	to	TO	I-NP	O
4	4	CD	I-NP	O
puffs	puff	NNS	I-NP	O
q.i.d.	q.i.d.	VBP	B-VP	O
p.r.n.	p.r.n.	NN	B-NP	O
17	17	CD	I-NP	O
.	.	.	O	O

Darbepoetin	Darbepoetin	NN	B-NP	O
alpha	alpha	SYM	I-NP	O
100	100	CD	I-NP	O
mcg	mcg	NN	I-NP	O
subcutaneously	subcutaneously	RB	B-ADVP	O
every	every	DT	B-NP	O
week	week	NN	I-NP	O
.	.	.	O	O

18	18	CD	B-NP	O
.	.	.	O	O

Xenaderm	Xenaderm	NN	B-NP	O
topically	topically	RB	B-ADVP	O
b.i.d.	b.i.d.	RB	B-NP	O
19	19	CD	I-NP	O
.	.	.	O	O

Ativan	Ativan	NNP	B-NP	O
NG	NG	NNP	I-NP	O
tube	tube	VBP	B-VP	O
0.521	0.521	CD	B-NP	O
mg	mg	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
anxiety	anxiety	NN	I-NP	O
.	.	.	O	O

20	20	CD	B-NP	O
.	.	.	O	O

Trazodone	Trazodone	NN	B-NP	O
50	50	CD	I-NP	O
mg	mg	NN	I-NP	O
PO	PO	NN	I-NP	O
q.h.s.	q.h.s.	NN	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
insomnia	insomnia	NN	I-NP	O
.	.	.	O	O

21	21	CD	B-NP	O
.	.	.	O	O

Oxycodone	Oxycodone	NN	B-NP	O
1	1	CD	I-NP	O
mg/mL	mg/mL	NN	I-NP	O
,	,	,	O	O
10	10	CD	B-NP	O
mg	mg	NN	I-NP	O
solution	solution	NN	I-NP	O
via	via	IN	B-PP	O
T-tube	T-tube	JJ	B-NP	O
q.	q.	NN	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
50-year-old	50-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
who	who	WP	B-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
Arlricks	Arlricks	NNP	B-NP	O
Community	Community	NNP	I-NP	O
Hospital	Hospital	NNP	I-NP	O
on	on	IN	B-PP	O
March	March	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
with	with	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
failure	failure	NN	I-NP	O
and	and	CC	I-NP	O
fever	fever	NN	I-NP	O
diagnosed	diagnose	VBN	B-VP	O
with	with	IN	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
and	and	CC	I-NP	O
COPD	COPD	NN	I-NP	O
flare	flare	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
empirically	empirically	RB	B-ADVP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

Sputum	Sputum	NN	B-NP	O
culture	culture	NN	I-NP	O
was	be	VBD	B-VP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
Pseudomonas	Pseudomonas	NNP	B-NP	O
and	and	CC	O	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
and	and	CC	I-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
noted	note	VBN	B-VP	O
at	at	IN	B-PP	O
Ieldha	Ieldha	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
4/4	4/4	CD	B-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
positive	positive	JJ	B-ADJP	O
for	for	IN	B-PP	O
coagulation-negative	coagulation-negative	JJ	B-NP	O
Staphylococcus	Staphylococcus	NNP	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
course	course	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
other	other	JJ	B-NP	O
medical	medical	JJ	I-NP	O
issues	issue	NNS	I-NP	O
including	include	VBG	B-PP	O
:	:	:	O	O
Non-ST	Non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
upper	upper	JJ	B-NP	O
gastrointestinal	gastrointestinal	JJ	I-NP	O
bleed	bleed	NN	I-NP	O
due	due	JJ	B-PP	O
to	to	TO	B-PP	O
supratherapeutic	supratherapeutic	JJ	B-NP	O
INR	INR	NN	I-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
had	have	VBD	B-VP	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
7.7	7.7	CD	B-NP	O
,	,	,	O	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
IV	IV	CD	B-NP	O
contrast	contrast	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
O	O	NNP	B-NP	O
Medical	Medical	NNP	I-NP	O
Center	Center	NNP	I-NP	O
ICU	ICU	NNP	I-NP	O
after	after	IN	B-PP	O
going	go	VBG	B-VP	O
into	into	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
distress	distress	NN	I-NP	O
at	at	IN	B-PP	O
Sti	Sti	NNP	B-NP	O
Versut	Versut	NNP	I-NP	O
Center	Center	NNP	I-NP	O
,	,	,	O	O
for	for	IN	B-PP	O
which	which	WDT	B-NP	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
at	at	IN	B-PP	O
Onnau	Onnau	NNP	B-NP	O
Hospital	Hospital	NNP	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
the	the	DT	B-NP	O
shore	shore	NN	I-NP	O
health	health	NN	I-NP	O
center	center	NN	I-NP	O
surgical	surgical	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
Quinla	Quinla	NNP	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
improvement	improvement	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
acute	acute	JJ	I-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
creatinine	creatinine	NN	I-NP	O
improving	improve	VBG	B-VP	O
to	to	TO	B-PP	O
2.0	2.0	CD	B-NP	O
range	range	NN	I-NP	O
.	.	.	O	O

With	With	IN	B-PP	O
IV	IV	CD	B-NP	O
fluids	fluid	NNS	I-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
non-ST	non-ST	JJ	I-NP	O
elevation	elevation	NN	I-NP	O
MI	MI	NN	I-NP	O
appeared	appear	VBD	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
resolving	resolve	VBG	I-VP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ongoing	ongoing	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
despite	despite	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

Noted	Note	VBN	B-VP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
CT	CT	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
free	free	JJ	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
taken	take	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
June	June	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
sigmoid	sigmoid	JJ	B-NP	O
colectomy	colectomy	NN	I-NP	O
with	with	IN	B-PP	O
colostomy	colostomy	NN	B-NP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
remained	remain	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
postoperatively	postoperatively	RB	B-ADVP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
transferred	transfer	VBN	I-VP	O
to	to	TO	B-PP	O
Ins	Ins	NNP	B-NP	O
Surgical	Surgical	JJ	I-NP	O
ICU	ICU	NN	I-NP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
broad-spectrum	broad-spectrum	NN	B-NP	O
antibiotics	antibiotic	NNS	I-NP	O
including	include	VBG	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
ceftazidime	ceftazidime	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
fluconazole	fluconazole	NN	B-NP	O
for	for	IN	B-PP	O
fungemia	fungemia	NN	B-NP	O
.	.	.	O	O

Intraoperatively	Intraoperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
perforation	perforation	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colon	colon	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
,	,	,	O	O
required	require	VBD	B-VP	O
Levophed	Levophe	VBN	I-VP	O
and	and	CC	O	O
vasopressin	vasopressin	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ongoing	ongoe	VBG	I-VP	O
respiratory	respiratory	JJ	B-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
required	require	VBD	B-VP	O
reintubation	reintubation	NN	B-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
brief	brief	JJ	I-NP	O
period	period	NN	I-NP	O
of	of	IN	B-PP	O
extubation	extubation	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
operating	operating	NN	I-NP	O
room	room	NN	I-NP	O
on	on	IN	B-PP	O
October	October	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
where	where	WRB	B-ADVP	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ileostomy	ileostomy	NN	I-NP	O
,	,	,	O	O
T-tube	T-tube	JJ	B-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
a	a	DT	B-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
explored	explore	VBN	I-VP	O
and	and	CC	O	O
adhesions	adhesion	NNS	B-NP	O
were	be	VBD	B-VP	O
lysed	lyse	VBN	I-VP	O
.	.	.	O	O

Postoperatively	Postoperatively	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
further	further	JJ	B-NP	O
improvement	improvement	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
improvement	improvement	NN	B-NP	O
in	in	IN	B-PP	O
acidosis	acidosis	NN	B-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
had	have	VBD	B-VP	O
ongoing	ongoing	JJ	B-NP	O
slow	slow	JJ	I-NP	O
wean	wean	NN	I-NP	O
off	off	IN	B-PP	O
the	the	DT	B-NP	O
ventilator	ventilator	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
on	on	IN	B-PP	O
followup	followup	NN	B-NP	O
CT	CT	NN	I-NP	O
to	to	TO	B-VP	O
have	have	VB	I-VP	O
intraabdominal	intraabdominal	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
collections	collection	NNS	I-NP	O
along	along	IN	B-PP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
January	January	NNP	B-NP	O
,	,	,	O	O
2005	2005	CD	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
CT-guided	CT-guided	JJ	I-NP	O
drainage	drainage	NN	I-NP	O
and	and	CC	I-NP	O
placement	placement	NN	I-NP	O
of	of	IN	B-PP	O
a	a	DT	B-NP	O
drain	drain	NN	I-NP	O
for	for	IN	B-PP	O
one	one	CD	B-NP	O
of	of	IN	B-PP	O
these	these	DT	B-NP	O
fluid	fluid	NN	I-NP	O
collections	collection	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
some	some	DT	B-NP	O
ongoing	ongoing	JJ	I-NP	O
improvement	improvement	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
Flagyl	Flagyl	NN	B-NP	O
,	,	,	O	O
fluconazole	fluconazole	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ceftazidime	ceftazidime	NN	B-NP	O
post	post	NN	I-NP	O
procedurally	procedurally	RB	B-ADVP	O
.	.	.	O	O

Repeat	Repeat	NN	B-NP	O
cultures	culture	NNS	I-NP	O
of	of	IN	B-PP	O
sputum	sputum	NN	B-NP	O
yielded	yield	VBD	B-VP	O
ongoing	ongoing	JJ	B-NP	O
Pseudomonas	Pseudomonas	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
sputum	sputum	NN	I-NP	O
sensitive	sensitive	JJ	B-ADJP	O
to	to	TO	B-VP	O
ceftazidime	ceftazidime	VB	I-VP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
noted	note	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
Aspergillus	Aspergillus	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
sputum	sputum	NN	I-NP	O
.	.	.	O	O

Thought	Think	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
possible	possible	JJ	B-NP	O
colonization	colonization	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
airways	airway	NNS	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
followup	followup	NN	B-NP	O
CT	CT	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
ongoing	ongoing	JJ	B-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
daily	daily	JJ	B-NP	O
fevers	fever	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
central	central	JJ	I-NP	O
lines	line	NNS	I-NP	O
and	and	CC	O	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
change-out	change-out	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	B-cell_line
arterial	arterial	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
.	.	.	O	O

He	He	PRP	B-NP	O
also	also	RB	B-ADVP	O
obtained	obtain	VBD	B-VP	O
a	a	DT	B-NP	O
tagged	tag	VBN	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
scan	scan	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
revealed	reveal	VBD	B-VP	O
an	an	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
enhancement	enhancement	NN	B-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
right	right	JJ	I-NP	O
lower	low	JJR	I-NP	O
quadrant	quadrant	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
possible	possible	JJ	B-NP	O
abscess	abscess	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
this	this	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
decreasing	decrease	VBG	I-VP	O
frequency	frequency	NN	B-NP	O
of	of	IN	B-PP	O
fevers	fever	NNS	B-NP	O
with	with	IN	B-PP	O
discontinuation	discontinuation	NN	B-NP	O
of	of	IN	B-PP	O
lines	line	NNS	B-NP	O
and	and	CC	O	O
continuation	continuation	NN	B-NP	O
of	of	IN	B-PP	O
antibiotics	antibiotic	NNS	B-NP	O
.	.	.	O	O

Moreover	Moreover	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
enhancement	enhancement	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
tagged	tag	VBN	I-NP	O
cell	cell	NN	I-NP	O
scan	scan	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
correlate	correlate	VB	I-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
significant	significant	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
on	on	IN	B-PP	O
abdominal	abdominal	JJ	B-NP	O
CT.	CT.	NNP	I-NP	O
.	.	.	O	O

After	After	IN	B-PP	O
consultation	consultation	NN	B-NP	O
with	with	IN	B-PP	O
the	the	DT	B-NP	O
Infectious	Infectious	NNP	I-NP	O
Disease	Disease	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
Interventional	Interventional	NNP	B-NP	O
Radiology	Radiology	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
Surgical	Surgical	NNP	I-NP	O
Service	Service	NNP	I-NP	O
,	,	,	O	O
it	it	PRP	B-NP	O
was	be	VBD	B-VP	O
decided	decide	VBN	I-VP	O
that	that	IN	B-SBAR	O
there	there	EX	B-NP	O
would	would	MD	B-VP	O
be	be	VB	I-VP	O
no	no	DT	B-NP	O
intervention	intervention	NN	I-NP	O
done	do	VBN	B-ADJP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
collection	collection	NN	I-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
now	now	RB	B-ADVP	O
is	be	VBZ	B-VP	O
starting	start	VBG	I-VP	O
PO	PO	NN	B-NP	B-protein
and	and	CC	O	O
is	be	VBZ	B-VP	O
having	have	VBG	I-VP	O
ongoing	ongoing	JJ	B-NP	O
low-grade	low-grade	JJ	I-NP	O
temperatures	temperature	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
clinically	clinically	RB	B-VP	O
improving	improve	VBG	I-VP	O
.	.	.	O	O

From	From	IN	B-PP	O
the	the	DT	B-NP	O
respiratory	respiratory	JJ	I-NP	O
standpoint	standpoint	NN	I-NP	O
,	,	,	O	O
was	be	VBD	B-VP	O
liberated	liberate	VBN	I-VP	O
from	from	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
prior	prior	JJ	I-NP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-DNA
.	.	.	O	O

LABORATORY	LABORATORY	NN	B-NP	O
DATA	DATA	NN	I-NP	O
:	:	:	O	O
White	White	JJ	B-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	B-protein
27	27	CD	I-NP	I-protein
,	,	,	O	O
platelets	platelet	NNS	B-NP	B-cell_type
443	443	CD	B-NP	O
.	.	.	O	O

Chem	Chem	NNP	B-NP	O
7	7	CD	I-NP	O
:	:	:	O	O
Sodium	Sodium	NN	B-NP	O
134	134	CD	I-NP	O
,	,	,	O	O
potassium	potassium	NN	B-NP	O
4.3	4.3	CD	I-NP	O
,	,	,	O	O
chloride	chloride	NN	B-NP	O
95	95	CD	I-NP	O
,	,	,	O	O
bicarbonate	bicarbonate	NN	B-NP	O
28	28	CD	I-NP	O
,	,	,	O	O
BUN	BUN	NN	B-NP	B-DNA
36	36	CD	I-NP	I-DNA
,	,	,	O	O
creatinine	creatinine	NN	B-NP	O
1.7	1.7	CD	I-NP	O
,	,	,	O	O
calcium	calcium	NN	B-NP	O
9.1	9.1	CD	I-NP	O
.	.	.	O	O

PT	PT	NN	B-NP	B-protein
14.9	14.9	CD	I-NP	I-protein
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
1.2	1.2	CD	I-NP	I-protein
,	,	,	O	O
PTT	PTT	NN	B-NP	B-protein
34.1	34.1	CD	I-NP	I-protein
.	.	.	O	O

ASSESSMENT	ASSESSMENT	NN	B-NP	O
AND	AND	CC	I-NP	O
PLAN	PLAN	NN	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
50-year-old	50-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
history	history	NN	B-NP	O
of	of	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
,	,	,	O	O
who	who	WP	B-NP	O
is	be	VBZ	B-VP	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
colectomy	colectomy	NN	I-NP	O
with	with	IN	B-PP	O
ileostomy	ileostomy	NN	B-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
perforated	perforate	VBN	B-NP	O
sigmoid	sigmoid	JJ	I-NP	O
colon	colon	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
for	for	IN	B-PP	O
respiratory	respiratory	JJ	B-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
prolonged	prolong	VBD	B-VP	O
ICU	ICU	NN	B-NP	O
course	course	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
pneumonia	pneumonia	NN	B-NP	O
,	,	,	O	O
sepsis	sepsis	NN	B-NP	O
,	,	,	O	O
acute	acute	JJ	B-ADJP	O
on	on	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
paroxysmal	paroxysmal	JJ	B-NP	O
atrial	atrial	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
now	now	RB	B-ADVP	O
off	off	RP	B-PRT	O
sedative	sedative	JJ	B-NP	O
drips	drip	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
alert	alert	JJ	B-ADJP	O
and	and	CC	O	O
oriented	orient	VBN	B-VP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
secondary	secondary	JJ	B-ADJP	O
to	to	TO	B-PP	O
degenerative	degenerative	JJ	B-NP	O
lower	low	JJR	I-NP	O
back	back	NN	I-NP	O
disease	disease	NN	I-NP	O
;	;	:	O	O
however	however	RB	B-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
current	current	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

Psychiatric	Psychiatric	JJ	B-NP	O
consult	consult	NN	I-NP	O
was	be	VBD	B-VP	O
obtained	obtain	VBN	I-VP	O
and	and	CC	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
adjustment	adjustment	NN	I-NP	O
disorder	disorder	NN	I-NP	O
with	with	IN	B-PP	O
anxiety	anxiety	NN	B-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
oxycodone	oxycodone	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
and	and	CC	O	O
continue	continue	VB	B-VP	O
Ativan	Ativan	NNP	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
Status	Status	NNP	B-NP	O
post	post	VBD	B-VP	O
non-ST	non-ST	JJ	B-NP	O
elevation	elevation	NN	I-NP	O
myocardial	myocardial	JJ	I-NP	O
infarction	infarction	NN	I-NP	O
,	,	,	O	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
30	30	CD	B-NP	O
%	%	NN	I-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
no	no	DT	B-NP	O
further	further	JJ	I-NP	O
signs	sign	NNS	I-NP	O
of	of	IN	B-PP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
by	by	IN	B-PP	O
x-ray	x-ray	NN	B-NP	O
or	or	CC	B-PP	O
by	by	IN	B-PP	O
clinical	clinical	JJ	B-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
off	off	IN	B-PP	O
pressors	pressor	NNS	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
hemodynamically	hemodynamically	RB	B-ADJP	O
stable	stable	JJ	I-ADJP	O
and	and	CC	O	O
in	in	IN	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

Plan	Plan	NN	B-NP	O
is	be	VBZ	B-VP	O
to	to	TO	B-VP	O
continue	continue	VB	I-VP	O
amiodarone	amiodarone	NN	B-NP	O
via	via	IN	B-PP	O
T	T	NN	B-NP	O
tube	tube	NN	I-NP	O
and	and	CC	O	O
continue	continue	JJ	B-NP	O
digoxin	digoxin	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
diurese	diurese	VB	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
I	I	PRP	B-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
even	even	RB	B-ADVP	O
.	.	.	O	O

Respiratory	Respiratory	JJ	B-ADJP	O
:	:	:	O	O
Continues	Continue	NNS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
slow	slow	JJ	B-NP	O
steroid	steroid	NN	I-NP	O
wean	wean	NN	I-NP	O
.	.	.	O	O

Liberated	Liberate	VBN	B-VP	O
from	from	IN	B-PP	O
mechanical	mechanical	JJ	B-NP	O
ventilation	ventilation	NN	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
transfer	transfer	VB	I-VP	O
out	out	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
ICU	ICU	NN	I-NP	B-protein
.	.	.	O	O

S/p	S/p	NN	B-NP	O
tracheostomy	tracheostomy	NN	I-NP	O
,	,	,	O	O
history	history	NN	B-NP	O
chronic	chronic	JJ	I-NP	O
obstructive	obstructive	JJ	I-NP	O
pulmonary	pulmonary	JJ	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
completing	complete	VBG	B-VP	O
course	course	NN	B-NP	O
of	of	IN	B-PP	O
Pseudomonas	Pseudomonas	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
treatments	treatment	NNS	I-NP	O
on	on	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
.	.	.	O	O

Gastrointestinal	Gastrointestinal	JJ	B-ADJP	O
:	:	:	O	O
Continues	Continue	NNS	B-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
goal	goal	NN	B-NP	O
rate	rate	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
start	start	VB	I-VP	O
advancing	advance	VBG	I-VP	O
PO	PO	NN	B-NP	O
diet	diet	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
plan	plan	NN	I-NP	O
to	to	TO	B-VP	O
wean	wean	VB	I-VP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
as	as	IN	B-PP	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
able	able	JJ	B-ADJP	O
to	to	TO	B-VP	O
tolerate	tolerate	VB	I-VP	O
further	further	RBR	B-ADVP	O
PO	PO	NNP	B-NP	O
's	's	POS	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
plan	plan	VB	I-VP	O
to	to	TO	I-VP	O
start	start	VB	I-VP	O
PO	PO	NN	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
.	.	.	O	O

FEN/GU	FEN/GU	NN	B-NP	O
:	:	:	O	O
Chronic	Chronic	JJ	B-NP	O
renal	renal	JJ	I-NP	O
insufficiency	insufficiency	NN	I-NP	O
with	with	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
1.5	1.5	CD	B-NP	O
to	to	TO	B-PP	O
1.7	1.7	CD	B-NP	O
.	.	.	O	O

Acute	Acute	JJ	B-NP	O
renal	renal	JJ	I-NP	O
failure	failure	NN	I-NP	O
,	,	,	O	O
resolved	resolve	VBN	B-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
good	good	JJ	B-NP	O
urine	urine	NN	I-NP	O
output	output	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
major	major	JJ	I-NP	O
electrolyte	electrolyte	NN	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
diurese	diurese	VB	I-VP	O
with	with	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
to	to	TO	B-VP	O
keep	keep	VB	I-VP	O
I	I	PRP	B-NP	O
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
even	even	RB	B-ADVP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
remains	remain	VBZ	B-VP	O
on	on	IN	B-PP	O
insulin	insulin	NN	B-NP	B-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
titrate	titrate	VB	I-VP	O
to	to	TO	I-VP	O
keep	keep	VB	I-VP	O
euglycemic	euglycemic	JJ	B-ADJP	O
.	.	.	O	O

Heme	Heme	NN	B-NP	B-protein
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
anemic	anemic	JJ	B-ADJP	O
with	with	IN	B-PP	O
hematocrits	hematocrit	NNS	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
mid	mid	NN	I-NP	O
20s	20s	CD	I-NP	O
and	and	CC	O	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
stable	stable	JJ	B-ADJP	O
,	,	,	O	O
likely	likely	RB	B-ADJP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
nutrition	nutrition	NN	B-NP	O
and	and	CC	I-NP	O
anemia	anemia	NN	I-NP	O
of	of	IN	B-PP	O
chronic	chronic	JJ	B-NP	O
disease	disease	NN	I-NP	O
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
watch	watch	VB	I-VP	O
hematocrit	hematocrit	NN	B-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
and	and	CC	O	O
continue	continue	VB	B-VP	O
DVT	DVT	NN	B-NP	O
prophylaxis	prophylaxis	NN	I-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
Currently	Currently	RB	B-ADVP	O
on	on	IN	B-PP	O
day	day	NN	B-NP	O
#	#	SYM	O	O
19	19	CD	B-NP	O
of	of	IN	B-PP	O
ceftazidime	ceftazidime	NN	B-NP	O
of	of	IN	B-PP	O
21	21	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
doing	do	VBG	I-VP	O
well	well	RB	B-ADVP	O
off	off	IN	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
,	,	,	O	O
fluconazole	fluconazole	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
Flagyl	Flagyl	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
has	have	VBZ	B-VP	O
been	be	VBN	I-VP	O
having	have	VBG	I-VP	O
low-grade	low-grade	JJ	B-NP	O
temperatures	temperature	NNS	I-NP	O
,	,	,	O	O
but	but	CC	O	O
improved	improve	VBD	B-VP	O
from	from	IN	B-PP	O
the	the	DT	B-NP	O
last	last	JJ	I-NP	B-protein
several	several	JJ	I-NP	I-protein
weeks	week	NNS	I-NP	I-protein
.	.	.	O	O

We	We	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
to	to	TO	I-VP	O
monitor	monitor	VB	I-VP	O
JP	JP	NN	B-NP	O
output	output	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
to	to	TO	B-VP	O
follow	follow	VB	I-VP	O
clinically	clinically	RB	B-ADVP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
noted	note	VBN	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
an	an	DT	B-NP	O
ongoing	ongoing	JJ	I-NP	O
fluid	fluid	NN	I-NP	O
collection	collection	NN	I-NP	O
in	in	IN	B-PP	O
his	his	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
and	and	CC	O	O
may	may	MD	B-VP	O
warrant	warrant	VB	I-VP	O
a	a	DT	B-NP	O
followup	followup	NN	I-NP	O
CT	CT	NN	I-NP	O
at	at	IN	B-PP	O
some	some	DT	B-NP	O
point	point	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
future	future	NN	I-NP	O
.	.	.	O	O

Transferred	Transfer	VBN	B-VP	O
to	to	TO	B-PP	O
floor	floor	NN	B-NP	O
with	with	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
monitoring	monitoring	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
condition	condition	NN	I-NP	O
is	be	VBZ	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-1653219	4-1653219	CD	B-NP	O
ISSten	ISSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
HEUSNER	HEUSNER	NN	B-NP	O
,	,	,	O	O
BENTON	BENTON	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
SCHILMOELLER	SCHILMOELLER	NN	B-NP	O
,	,	,	O	O
NATHANAEL	NATHANAEL	NNP	B-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0479349	0479349	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
7/20/05	7/20/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
7/20/05	7/20/05	CD	B-NP	O

